Latest news with #Sarbanes-OxleyActof2002
Business Upturn
31-05-2025
- Business
- Business Upturn
Grupo Aeroportuario del Pacifico Announces Drawdown of Ps. 3,375 Million Credit Facility
By GlobeNewswire Published on May 31, 2025, 02:29 IST GUADALAJARA, Mexico, May 30, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) ('the Company' or 'GAP') announces that today it drew down a credit facility with Banco Nacional de México, S.A. ('Banamex') for Ps. 3,375 million, with a five-year term. Interest will be payable monthly at a variable rate of TIIE-28 (Funding) plus 54 basis points, without fees and principal payment on May 30, 2030, The proceeds from this credit will be used to repay existing bank loans currently held with Banamex of Ps. 2,500 million and BBVA of Ps. 875 million. Company Description Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico's Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Guanajuato, Morelia, Aguascalientes, Mexicali, and Los Mochis. In February 2006, GAP's shares were listed on the New York Stock Exchange under the ticker symbol 'PAC' and on the Mexican Stock Exchange under the ticker symbol 'GAP'. In April 2015, GAP acquired 100% of Desarrollo de Concessioner Aeroportuarias, S.L., which owns a majority stake in MBJ Airports Limited, a company operating Sangster International Airport in Montego Bay, Jamaica. In October 2018, GAP entered into a concession agreement for the Norman Manley International Airport operation in Kingston, Jamaica, and took control of the operation in October 2019. This press release may contain forward-looking statements. These statements are statements that are not historical facts and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance, and financial results. The words 'anticipates', 'believes', 'estimates', 'expects', 'plans' and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations, and the factors or trends affecting financial condition, liquidity, or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends, or results will occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations. In accordance with Section 806 of the Sarbanes-Oxley Act of 2002 and Article 42 of the 'Ley del Mercado de Valores', GAP has implemented a 'whistleblower' program, which allows complainants to anonymously and confidentially report suspected activities that involve criminal conduct or violations. The telephone number in Mexico, facilitated by a third party responsible for collecting these complaints, is 800 04 ETICA (38422) or WhatsApp +52 55 6538 5504. The website is or by email at [email protected]. GAP's Audit Committee will be notified of all complaints for immediate investigation. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
30-05-2025
- Business
- Yahoo
Grupo Aeroportuario del Pacifico Announces Drawdown of Ps. 3,375 Million Credit Facility
GUADALAJARA, Mexico, May 30, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) ('the Company' or 'GAP') announces that today it drew down a credit facility with Banco Nacional de México, S.A. ('Banamex') for Ps. 3,375 million, with a five-year term. Interest will be payable monthly at a variable rate of TIIE-28 (Funding) plus 54 basis points, without fees and principal payment on May 30, 2030, The proceeds from this credit will be used to repay existing bank loans currently held with Banamex of Ps. 2,500 million and BBVA of Ps. 875 million. Company Description Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico's Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Guanajuato, Morelia, Aguascalientes, Mexicali, and Los Mochis. In February 2006, GAP's shares were listed on the New York Stock Exchange under the ticker symbol 'PAC' and on the Mexican Stock Exchange under the ticker symbol 'GAP'. In April 2015, GAP acquired 100% of Desarrollo de Concessioner Aeroportuarias, S.L., which owns a majority stake in MBJ Airports Limited, a company operating Sangster International Airport in Montego Bay, Jamaica. In October 2018, GAP entered into a concession agreement for the Norman Manley International Airport operation in Kingston, Jamaica, and took control of the operation in October 2019. This press release may contain forward-looking statements. These statements are statements that are not historical facts and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance, and financial results. The words 'anticipates', 'believes', 'estimates', 'expects', 'plans' and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations, and the factors or trends affecting financial condition, liquidity, or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends, or results will occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations. In accordance with Section 806 of the Sarbanes-Oxley Act of 2002 and Article 42 of the 'Ley del Mercado de Valores', GAP has implemented a 'whistleblower' program, which allows complainants to anonymously and confidentially report suspected activities that involve criminal conduct or violations. The telephone number in Mexico, facilitated by a third party responsible for collecting these complaints, is 800 04 ETICA (38422) or WhatsApp +52 55 6538 5504. The website is or by email at denuncia@ GAP's Audit Committee will be notified of all complaints for immediate investigation. Alejandra Soto, Investor Relations and Social Responsibility Officer asoto@ Gisela Murillo, Investor Relations gmurillo@ 33 3880 1100 ext. 20294 Sign in to access your portfolio
Yahoo
22-05-2025
- Business
- Yahoo
WORK Medical Technology Group LTD Announces Closing of Registered Offering
Hangzhou, China, May 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ('WORK Medical' or the 'Company'), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the closing of a registered offering (the 'Offering') of 10,000,000 ordinary units (the 'Ordinary Units') at an offering price of $0.50 per Ordinary Unit. Each Ordinary Unit consists of one Class A ordinary share, par value $0.0005 (a 'Class A Ordinary Share'), one Series A warrant to purchase one Class A Ordinary Share at an exercise price of $1.00 (a 'Series A Warrant'), and one Series B warrant to purchase one Class A Ordinary Share at an exercise price of $1.00 (a 'Series B Warrant'). The Series A Warrants and Series B Warrants are immediately exercisable upon issuance, with the Series A Warrants expiring in 12 months, and Series B Warrants expiring in 3 months. The Company received aggregate gross proceeds of US$5.0 million from the Offering, before deducting underwriting discounts and other related expenses. Proceeds from the Offering will be used for upgrading production equipment and investing in the Company's PRC subsidiaries' research and development; hiring experienced employees to improve the systems of internal control and compliance with U.S. GAAP and the Sarbanes-Oxley Act of 2002; and working capital and general corporate purposes. The Offering was conducted on a firm commitment basis. Univest Securities, LLC acted as the sole book-running manager for the Offering. The securities described above were offered by the Company pursuant to a registration statement on Form F-1 (File No. 333-284006), as amended (the 'Registration Statement'), previously filed with and declared effective by the U.S. Securities and Exchange Commission (the 'SEC'). This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The Offering was made only by means of a prospectus forming part of the effective Registration Statement. A final prospectus related to the Offering was filed with the SEC and is available on the SEC's website at Electronic copies of the final prospectus may be obtained from Univest Securities, LLC at info@ or by calling +1 (212) 343-8888. About WORK Medical Technology Group LTD WORK Medical Technology Group LTD, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company's website: press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as 'aims,' 'anticipates,' 'believes,' 'could,' 'estimates,' 'expects,' 'forecasts,' 'goal,' 'intends,' 'may,' 'plans,' 'possible,' 'potential,' 'seeks,' 'will,' and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Any forward-looking statements in this press release are based on the Company's current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company's annual report on Form 20-F for the fiscal year ended September 30, 2024, the Registration Statement and other documents filed by the Company with the SEC. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. For more information, please contact: WORK Medical Technology Group LTD Investor Relations Department Email: ir@ Ascent Investor Relations LLC Tina Xiao Phone: +1 646-932-7242 Email: investors@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
WORK Medical Technology Group LTD Announces Pricing of Registered Offering
Hangzhou, China, May 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ('WORK Medical' or the 'Company'), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the pricing of a registered offering (the 'Offering') of 10,000,000 ordinary units (the 'Ordinary Units') or pre-funded units (the 'Pre-funded Units') in lieu thereof at an offering price of $0.50 per Ordinary Unit and $0.4995 per Pre-funded Unit. For each Pre-funded Unit sold by the Company, the number of Ordinary Units being offered by the Company will be decreased on a one-for-one basis. Each Ordinary Unit consists of one Class A ordinary share, par value $0.0005 (a 'Class A Ordinary Share'), one Series A warrant to purchase one Class A Ordinary Share at an exercise price of $1.00 (a 'Series A Warrant'), and one Series B warrant to purchase one Class A Ordinary Share at an exercise price of $1.00 (a 'Series B Warrant'). Each Pre-funded Units consists of one pre-funded warrant to purchase one Class A Ordinary Share (a 'Pre-funded Warrant'), one Series A Warrant, and one Series B Warrant. The Pre-funded Warrants, Series A Warrants, and Series B Warrants are immediately exercisable upon issuance, with the Pre-funded Warrants expiring upon full exercise, Series A Warrants expiring in 12 months, and Series B Warrants expiring in 3 months. The Company expects to receive aggregate gross proceeds of US$5.0 million from the Offering, before deducting underwriting discounts and other related expenses. Proceeds from the Offering will be used for upgrading production equipment and investing in the Company's PRC subsidiaries' research and development; hiring experienced employees to improve the systems of internal control and compliance with U.S. GAAP and the Sarbanes-Oxley Act of 2002; and working capital and general corporate purposes. The Offering is being conducted on a firm commitment basis. Univest Securities, LLC is acting as the sole book-running manager for the Offering. The securities described above are being offered by the Company pursuant to a registration statement on Form F-1 (File No. 333-284006), as amended (the 'Registration Statement'), previously filed with and declared effective by the U.S. Securities and Exchange Commission (the 'SEC'). This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The Offering is being made only by means of a prospectus forming part of the effective Registration Statement. A final prospectus related to the Offering will be filed with the SEC and will be available on the SEC's website at Electronic copies of the final prospectus may be obtained, when available, from Univest Securities, LLC at info@ or by calling +1 (212) 343-8888. About WORK Medical Technology Group LTD WORK Medical Technology Group LTD, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company's website: press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as 'aims,' 'anticipates,' 'believes,' 'could,' 'estimates,' 'expects,' 'forecasts,' 'goal,' 'intends,' 'may,' 'plans,' 'possible,' 'potential,' 'seeks,' 'will,' and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Any forward-looking statements in this press release are based on the Company's current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, among others, the completion of the proposed Offering on the anticipated terms, or at all, market conditions and the satisfaction of customary closing conditions related to the Offering. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company's annual report on Form 20-F for the fiscal year ended September 30, 2024, the Registration Statement and other documents filed by the Company with the SEC. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. For more information, please contact: WORK Medical Technology Group LTDInvestor Relations DepartmentEmail: ir@ Ascent Investor Relations LLCTina XiaoPhone: +1 646-932-7242Email: investors@ in to access your portfolio
Yahoo
14-05-2025
- Business
- Yahoo
Grupo Aeroportuario del Pacifico Announces Payment Date for the First Installment of the Dividend Approved by the Annual General Ordinary Shareholders' Meeting
GUADALAJARA, Mexico, May 14, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) ('the Company' or 'GAP') announces that, following the resolution adopted by the Annual General Ordinary Shareholders' Meeting held on April 24, 2025, regarding the payment of a total dividend of Ps. 16.84 (SIXTEEN PESOS 84/100 M.N.) per outstanding share, the Company decided to make the dividend payment in two installments. The first installment will be equivalent to Ps. 8.42 (EIGHT PESOS 42/100 M.N.) per outstanding share and will be paid on May 28, 2025. The dividend payment will correspond to the forty such payment. Company Description Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico's Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Guanajuato, Morelia, Aguascalientes, Mexicali, and Los Mochis. In February 2006, GAP's shares were listed on the New York Stock Exchange under the ticker symbol 'PAC' and on the Mexican Stock Exchange under the ticker symbol 'GAP'. In April 2015, GAP acquired 100% of Desarrollo de Concessioner Aeroportuarias, S.L., which owns a majority stake in MBJ Airports Limited, a company operating Sangster International Airport in Montego Bay, Jamaica. In October 2018, GAP entered into a concession agreement for the Norman Manley International Airport operation in Kingston, Jamaica, and took control of the operation in October 2019. This press release may contain forward-looking statements. These statements are statements that are not historical facts and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance, and financial results. The words 'anticipates', 'believes', 'estimates', 'expects', 'plans' and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations, and the factors or trends affecting financial condition, liquidity, or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends, or results will occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations. In accordance with Section 806 of the Sarbanes-Oxley Act of 2002 and Article 42 of the 'Ley del Mercado de Valores', GAP has implemented a 'whistleblower' program, which allows complainants to anonymously and confidentially report suspected activities that involve criminal conduct or violations. The telephone number in Mexico, facilitated by a third party responsible for collecting these complaints, is 800 04 ETICA (38422) or WhatsApp +52 55 6538 5504. The website is or by email at denuncia@ GAP's Audit Committee will be notified of all complaints for immediate investigation. Alejandra Soto, Investor Relations and Social Responsibility Officer asoto@ Gisela Murillo, Investor Relations gmurillo@ 33 3880 1100 ext. 20294
